Rt Hon JACINDA ARDERN: We do have some limitation around incoming supply, in terms of what we're able to say, from the pharmaceutical companies; they have some requirements on us on what we say about our delivery schedule. However, for a long time, a number of weeks, we have been very open about the fact that we are currently, because we have outstripped our targets—the DHBs have outstripped the targets—if we maintain our current trajectory we will be able to continue to deliver vaccines for those who are booked, but if there is any slippage in the delivery schedule, there is likely to be constrained supply. But that is, at this stage, only if our pharmaceutical company does not deliver as they intended to.